XML 71 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of Income Tax Expense Applying Statutory Federal Income Rate

A reconciliation of the Company’s income taxes to the amount computed by applying the statutory federal income tax rate to the pretax loss is summarized as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

Tax at statutory rates

 

$

(12,094

)

 

 

21.0

%

 

$

(4,323

)

 

 

21.0

%

State and local income taxes, net of federal income tax effect*

 

 

(136

)

 

 

0.2

%

 

 

(50

)

 

 

0.2

%

 Effects of changes in tax laws or rates in the current period

 

 

 

 

 

 

 

 

 

 

 

 

Tax credits:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development credits

 

 

(5,286

)

 

 

9.2

%

 

 

(2,986

)

 

 

14.5

%

Change in valuation allowance

 

 

15,766

 

 

 

(27.4

)%

 

 

6,146

 

 

 

(29.8

)%

Nontaxable or nondeductible items:

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense

 

 

221

 

 

 

(0.4

)%

 

 

84

 

 

 

(0.4

)%

Research expenses

 

 

 

 

 

 

 

 

347

 

 

 

(1.7

)%

Executive compensation

 

 

138

 

 

 

(0.2

)%

 

 

 

 

 

 

Permanent differences

 

 

20

 

 

 

 

 

 

(14

)

 

 

0.1

%

Changes in unrecognized tax benefits

 

 

1,371

 

 

 

(2.4

)%

 

 

796

 

 

 

(3.9

)%

Other, net

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax expense (benefit)

 

$

 

 

 

 

 

$

 

 

 

 

Schedule of Significant Components of Company's Deferred Income Taxes

Significant components of the Company’s deferred income taxes were as follows (in thousands):

 

 

 

December 31,

 

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforward

 

$

23,497

 

 

$

8,627

 

Capitalized R&D

 

 

3,731

 

 

 

4,202

 

Investment in securities

 

 

1,301

 

 

 

1,298

 

R&D tax credits

 

 

7,659

 

 

 

3,256

 

Allowance for receivables

 

 

711

 

 

696

 

Other, net

 

 

1,761

 

 

628

 

Total gross deferred tax assets

 

 

38,660

 

 

 

18,707

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of-use asset

 

 

(99

)

 

 

(206

)

Cash to accrual method change

 

 

(32

)

 

 

(63

)

Other, net

 

 

(7

)

 

 

(2

)

Total gross deferred tax liabilities

 

 

(138

)

 

 

(271

)

Valuation allowance

 

 

(38,522

)

 

 

(18,436

)

Net deferred tax assets

 

$

 

 

$

 

Summary of Reconciliation of amount of Unrecognized Tax Benefits

A reconciliation of the amount of unrecognized tax benefits is as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

Beginning balance

 

$

1,104

 

 

$

294

 

Additions related to current year positions

 

 

1,494

 

 

 

810

 

Additions (decreases) related to prior year positions

 

 

(86

)

 

 

 

Additions (decreases) due to settlement

 

 

 

 

 

 

Expiration of unrecognized tax benefits

 

 

 

 

 

 

Ending balance

 

$

2,512

 

 

$

1,104